The EIU's Index of Cancer Preparedness reveals huge gaps in health system readiness and governance
28 Mars 2019 - 08:00AM
JCN Newswire (English)
LONDON, Mar 28, 2019 - (Media OutReach) - * The Economist
Intelligence Unit (EIU) has created the Index of Cancer
Preparedness (ICP). It draws on a wide range of data relevant to
cancer policy and control from 28 countries. The aims of the ICP
are to allow benchmarking of national efforts and identify best
practice in addressing the cancer challenge.
* Australia tops the ICP, followed by the Netherlands and Germany.
Saudi Arabia, Romania and Egypt face the largest room for
improvement.
* The ICP explores the issue of cancer preparedness through three
broad domains: 1) policy and planning; 2) care delivery; and 3)
health systems and governance. The index found the biggest gaps in
the health system domain, especially in middle- and low-income
countries.
* The study accompanying the ICP identifies the four essentials of
cancer preparedness: essential investment (appropriate spending and
resources), roadmap (effective planning), foundation (functioning
health systems) and intelligence (availability and quality of
cancer-related data).
Cancer is the world's second biggest killer, responsible for 9.6m
deaths in 2018 - roughly one out of six across the globe - and the
leading or second largest cause of mortality before the age of 70
in over half the world's countries. Amid demographic changes such
as population ageing, cancer incidence is set to rise by 63%
between 2018 and 2040, according to the International Agency for
Research on Cancer. A new report by The Economist Intelligence Unit
looks at the complexities of this growing menace and at whether the
world is ready to face it.
Cancer preparedness around the world: National readiness for a
global epidemic, funded with support from Novartis, Pfizer and
Roche, introduces the Index of Cancer Preparedness (ICP), which
draws on a wide range of data relevant to cancer policy and control
from 28 countries. The aims of the ICP are to allow benchmarking of
national efforts and, even more, to initiate discussion on best
practice in addressing the cancer challenge. Australia tops the
ICP, followed by the Netherlands and Germany. Saudi Arabia, Romania
and Egypt face the largest room for improvement.
The ICP explores the issue of cancer preparedness through three
broad domains:
1. policy and planning;
2. care delivery; and
3. health systems and governance.
The index shows that the highest scores on average are found in
policy and planning. However, the countries' performances get
weaker when moving from policy to implementation to overall health
system readiness and governance. This is particularly the case in
middle- and low-income countries.
The report identifies the four essentials of cancer preparedness.
First, essential investment refers to appropriate spending and
resources dedicated to cancer care. Second essential roadmap refers
to effective planning, especially via national cancer control
plans. Third, essential foundation refers to the need to embed
cancer control in an accessible, general health system. And fourth,
essential intelligence refers to the need to measure the nature of
the challenge as well as how well interventions are working, for
example via population-based cancer registries.
Martin Koehring, managing editor at the EIU, added: "No health
system, no government and no society can afford a lukewarm response
to cancer. This group of diseases is already the world's second
biggest killer and costs the global economy upwards of US$1trn per
year. The ICP is a useful benchmarking tool to help policymakers
and other key stakeholders to identify where their countries stand
in cancer control compared with their peers and how they can boost
their preparedness."
View the index results and read the accompanying white paper.
https://bit.ly/2UZcQ2U
The content of this report is solely the responsibility of the
Economist Intelligence Unit and the views expressed are not
necessarily those of any of the sponsors.
About The Economist Intelligence Unit
The EIU is the thought leadership, research and analysis division
of The Economist Group and the world leader in global business
intelligence for executives. We uncover novel and forward-looking
perspectives with access to over 650 expert analysts and editors
across 200 countries worldwide. More information can be found on
www.eiuperspectives.economist.com. Follow us on Twitter, LinkedIn,
and Facebook
Press enquiries
Ulrike Haessler, Global Head of Marketing - Thought Leadership
T: +44 20 7576 8047
M: +44 78 4151 3573
E: ulrikehaessler@economist.com
Martin Koehring, Managing Editor & Global Healthcare Lead -
Thought Leadership
T: +44 20 7576 8028
M: +44 78 2562 0857
E: MartinKoehring@economist.com
Source: The Economist Intelligence Unit
Copyright 2019 ACN Newswire . All rights reserved.
Pfizer (NYSE:PFE)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Pfizer (NYSE:PFE)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024